CAS 110230-98-3

Talaporfin

Description:

Talaporfin, with the CAS number 110230-98-3, is a photosensitizing agent primarily used in photodynamic therapy (PDT) for the treatment of certain types of cancer. It is a derivative of porphyrin, a class of compounds known for their ability to absorb light and produce reactive oxygen species upon activation. Talaporfin is characterized by its ability to absorb light in the near-infrared region, which allows for deeper tissue penetration compared to other photosensitizers. This property enhances its efficacy in targeting tumors while minimizing damage to surrounding healthy tissues. Talaporfin is typically administered intravenously and is activated by specific wavelengths of light, leading to localized cytotoxic effects that induce apoptosis in cancer cells. Additionally, it has a favorable safety profile, with a relatively low incidence of side effects. Its development has contributed to advancements in minimally invasive cancer treatments, making it a significant compound in the field of oncology.

Formula: C₃₈H₄₁N₅O₉

InChI: InChI=1/C38H41N5O9/c1-7-20-16(3)24-12-26-18(5)22(9-10-32(45)46)35(42-26)23(11-31(44)41-30(37(49)50)15-33(47)48)36-34(38(51)52)19(6)27(43-36)14-29-21(8-2)17(4)25(40-29)13-28(20)39-24/h7,12-14,18,22,30,39-40H,1,8-11,15H2,2-6H3,(H,41,44)(H,45,46)(H,47,48)(H,49,50)(H,51,52)/b24-12-,25-13-,26-12-,27-14-,28-13-,29-14-,35-23-,36-23-/t18-,22-,30-/m0/s1

InChI key: InChIKey=VSEIDZLLWQQJGK-PIIKQHJPSA-N

SMILES: C(C(N[C@@H](CC(O)=O)C(O)=O)=O)C1=C2[C@@H](CCC(O)=O)[C@H](C)C(=N2)C=C3NC(C(C=C)=C3C)=CC4=NC(=CC=5NC1=C(C(O)=O)C5C)C(CC)=C4C

Synonyms:

• <span class="text-smallcaps">L</span>-Aspartic acid, N-[2-[(7S,8S)-3-carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetyl]-
• <span class="text-smallcaps">L</span>-Aspartic acid, N-[[(7S,8S)-3-carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetyl]-
• Aspartyl chlorin
• L-Aspartic acid, N-(3-(18-carboxy-20-(carboxymethyl)-8-ethenyl-13-ethyl-2,3-dihydro-3,7,12,17-tetramethyl-21H,23H-porphin-2-yl)-1-oxopropyl)-, (2S-trans)-
• Me 2906
• Mono-<span class="text-smallcaps">L</span>-aspartyl chlorin e₆
• Mono-L-aspartyl chlorin
• Mono-L-aspartyl chlorin e6
• Monoaspartyl chlorin
• N-Aspartyl chlorin e6
• N-Aspartylchlorin e6
• N-[2-[(7S,8S)-3-Carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetyl]-<span class="text-smallcaps">L</span>-aspartic acid
• N-{[(2S,3S)-7-carboxy-3-(2-carboxyethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3-dihydroporphyrin-5-yl]acetyl}-L-aspartic acid
• NPe 6
• NPe6
• Talaporfin
• Talaporfin [INN]
• Unii-P4Rox5Elt2
• N-[2-[(7S,8S)-3-Carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetyl]-L-aspartic acid
• Monoaspartyl chlorin e6
• L-Aspartic acid, N-[[(7S,8S)-3-carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetyl]-
• L-Aspartic acid, N-[2-[(7S,8S)-3-carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetyl]-
• Talaporfin free acid
• (2S)-2-[[2-[(2S,3S)-7-carboxy-3-(2-carboxyethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioic acid
• monoaspartyl chlorin e6 or 220201-34-3((sodium salt)

Talaporfin-13C4-15N

Controlled Product

CAS: 110230-98-3

Applications Talaporfin-13C4-15N is labelled Talaporfin which is a photosensitizer used in photodynamic therapy.
References Yoshinori, N., et al.: Photochem. Photobio., 85, 714 (2009); Gomer, C., et al.: Cancer Res., 56, 2355 (1996)

Formula: C₃₄₁₃C₄H₄₁N₄₁₅NO₉

Color and Shape: Neat

Molecular weight: 716.72

Ref: TR-T004972

Talaporfin free acid

CAS: 110230-98-3

Talaporfin, an effective tumor localizer, can produce the selective degradation of tumor tissue following light exposure.

Formula: C₃₈H₄₁N₅O₉

Color and Shape: Solid

Molecular weight: 711.76

Ref: TM-T34777